Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to ACSS1" (ENSG00000303964) is a long non-coding RNA identified in genomic databases as transcribed on the strand opposite to the ACSS1 gene, which encodes the mitochondrial enzyme acyl-CoA synthetase short-chain family member 1. Unlike ACSS1, whose protein product catalyzes acetate to acetyl-CoA conversion in mitochondria[1][3], this antisense RNA is not a protein-coding gene and is not recognized as a molecular target for drugs, biomarkers, or direct disease association in the literature. Its functional significance and expression profile remain uncharacterized, and it is not classified among major molecular families like receptors, channels, transporters, enzymes, or transcription factors[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to ACSS1.